Avanos Medical Inc (AVNS)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$12.50

Buy

$14.00

arrow-up$0.36 (+2.82%)

Prices updated at 16 May 2025, 21:05 EDT

Prices minimum 15 mins delay

Prices in USD

Halyard Health Inc is a medical technology company which provides healthcare supplies and solutions that target the prevention of healthcare associated infections. Its business segments include Surgical and Infection Prevention and Medical Devices.

S&P 500

0.7%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Devices

Chairman

Mr. Gary D. Blackford

CEO

Mr. David C. Pacitti

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

2,227

Head office

5405 Windward Parkway

Alpharetta

United States

30004

+1 844 428-2667

Investor.Relations@Avanos.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. David C. Pacitti Chief Executive Officer	-
Mr. Gary D. Blackford Chairman of the Board	0.21m
Mr. Patrick J. O'Leary Independent Director	0.10m
Dr. Julie A. Shimer, PhD Independent Director	0.10m
Mr. Warren J. Machan Interim Chief Financial Officer	0.33m
Ms. Indrani Lall Franchini, J.D. Independent Director	0.05m
Mr. Kerr W. Holbrook Senior Vice President and Chief Commercial Officer	0.50m
Ms. Mojirade James Senior Vice President, General Counsel and Secretary	0.47m
Dr. Lisa C. Egbuonu-Davis, M.D. Independent Director	0.09m
Mr. John Joseph Hurley Principal Accounting Officer and Controller	-
Mr. Sigfrido Delgado Senior Vice President, Integrated Supply Chain	0.30m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
BlackRock Inc	6,896,968
Vanguard Group Inc	5,348,297
BlackRock Fund Advisors	4,848,407
T. Rowe Price Investment Management,Inc.	3,011,312
iShares Core S&P Small-Cap ETF	2,778,804

Director dealings

Date chevron-l-regular chevron-r-regular	Action
03 Dec 2024	-
29 Oct 2024	-
05 Sep 2024	-
22 Jul 2024	-
18 Mar 2024	-
18 Mar 2024	-
18 Mar 2024	-
18 Mar 2024	-
18 Mar 2024	-
18 Mar 2024	-
18 Mar 2024	-
18 Mar 2024	-
18 Mar 2024	-
14 Mar 2024	-
14 Mar 2024	-
14 Mar 2024	-
14 Mar 2024	-
14 Mar 2024	-
14 Mar 2024	-
11 Mar 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.